Primary ICD-therapy in patients with advanced heart failure: Selection strategies and future trials

Clinical Research in Cardiology

Volumn 97, Issue 9, 2008, Pages 594-600

  Frankenstein, Lutz ^a   Zugck, Christian ^a   Nelles, Manfred ^a   Schellberg, Dieter ^a   Remppis, Andrew ^a   Katus, Hugo ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Advanced; Chronic heart failure; High risk; Primary prophylactic ICD

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART FAILURE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; GERMANY; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 51349126826     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-008-0656-7     Document Type: Article

References (30)

1. GH Bardy KL Lee DB Mark JE Poole DL Packer R Boineau M Domanski C Troutman J Anderson G Johnson SE McNulty N Clapp-Channing LD Davidson-Ray ES Fraulo DP Fishbein RM Luceri JH Ip Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators 2005 Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure N Engl J Med 352 225 237
2. MR Bristow LA Saxon J Boehmer S Krueger DA Kass T De Marco P Carson L DiCarlo D DeMets BG White DW DeVries AM Feldman Comparison of Medical Therapy, Pacing, Defibrillation in Heart Failure (COMPANION) Investigators 2004 Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2140 2150
3. WN Brodine RT Tung JK Lee ES Hockstad AJ Moss W Zareba WJ Hall M Andrews S McNitt JP Daubert MADIT-II Research Group 2005 Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II) Am J Cardiol 96 691 695
4. AE Buxton KL Lee JD Fisher ME Josephson EN Prystowsky G Hafley 1999 A randomized study of the prevention of sudden death in patients with coronary artery disease. multicenter unsustained tachycardia trial investigators N Engl J Med 341 1882 1890
5. AE Buxton KL Lee GE Hafley DG Wyse JD Fisher MH Lehmann LA Pires MR Gold DL Packer ME Josephson EN Prystowsky MR Talajic MUSTT Investigators 2002 Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease Circulation 106 2466 2472
6. AE Buxton 2005 Identifying the high risk patient with coronary artery disease-is ejection fraction all you need? J Cardiovasc Electrophysiol 16 Suppl 1 S25 S27
7. JG Cleland I Gemmell A Khand A Boddy 1999 Is the prognosis of heart failure improving Eur J Heart Fail 1 229 241
8. P de Groote J Dagorn B Soudan N Lamblin E McFadden C Bauters 2004 B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure J Am Coll Cardiol 43 1584 1589
9. AS Desai JC Fang WH Maisel KL Baughman 2004 Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials JAMA 292 2874 2879
10. APM Gorgels C Gijsbers J de Vreede-Swagemakers A Lousberg HJJ Wellens 2003 Out-of-hospital cardiac arrest-the relevance of heart failure. the Maastricht circulatory arrest registry Eur Heart 24 1204 1209
11. UC Hoppe 2007 Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists? Clin Res Cardiol 96 196 198
12. A Kadish M Mehra 2005 Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy Circulation 111 3327 3335
13. M Komajda P Lapuerta N Hermans JR Gonzalez-Juanatey DJ van Veldhuisen E Erdmann L Tavazzi P Poole-Wilson C Le Pen 2005 Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey Eur Heart J 26 1653 1659
14. DS Lee JV Tu DN Juurlink DA Alter DT Ko PC Austin A Chong TA Stukel D Levy A Laupacis 2005 Risk-treatment mismatch in the pharmacotherapy of heart failure JAMA 294 1240 1247
15. AJ Moss WJ Hall DS Cannom JP Daubert SL Higgins H Klein JH Levine S Saksena AL Waldo D Wilber MW Brown M Heo 1996 Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. multicenter automatic defibrillator implantation trial investigators N Engl J Med 335 1933 1940
16. AJ Moss A Vyas H Greenberg RB Case W Zareba WJ Hall MW Brown SA McNitt ML Andrews MADIT-II Research Group 2004 Temporal aspects of improved survival with the implanted defibrillator (MADIT-II) Am J Cardiol 94 312 315
17. AJ Moss W Zareba WJ Hall H Klein DJ Wilber DS Cannom JP Daubert SL Higgins MW Brown ML Andrews Multicenter Automatic Defibrillator Implantation Trial II Investigators 2002 Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 877 883
18. D Mozaffarian SD Anker I Anand DT Linker MD Sullivan JG Cleland PE Carson AP Maggioni DL Mann B Pitt PA Poole-Wilson WC Levy 2007 Prediction of mode of death in heart failure: the Seattle Heart Failure Model Circulation 116 392 398
19. K Nanthakumar AE Epstein GN Kay VJ Plumb DS Lee 2004 Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction a pooled analysis of 10 primary prevention trials J Am Coll Cardiol 44 2166 2172
20. Peters-Klimm F, Müller-Tasch T, Schellberg D, Remppis A, Barth A, Holzapfel N, Jünger J, Herzog W, Szecsenyi J (2007) Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy. Clin Res Cardiol [Epub ahead of print]
21. HF Pitschner J Neuzner E Himmrich A Liebrich J Jung A Heisel 1997 Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results J Interv Card Electrophysiol 1 211 220
22. R Reibis C Dovifat R Dissmann B Ehrlich S Schulz K Stolze K Wegscheider H Völler 2006 Implementation of evidence-based therapy in patients with systolic heart failure from 1998-2000 Clin Res Cardiol 95 154 161
23. MJ Reiter JA Reiffel 1998 Importance of beta blockade in the therapy of serious ventricular arrhythmias Am J Cardiol 82 9I 19I
24. TV Salukhe K Dimopoulos R Sutton AJ Coats M Piepoli DP Francis 2004 Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications Circulation 109 1848 1853
25. JP Singh WJ Hall S McNitt H Wang JP Daubert W Zareba JN Ruskin AJ Moss MADIT-II Investigators 2005 Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the multicenter automatic defibrillator implantation trial II (MADIT-II) J Am Coll Cardiol 46 1712 1720
26. SA Strickberger JD Hummel TG Bartlett HI Frumin CD Schuger SL Beau C Bitar F Morady AMIOVIRT Investigators 2003 Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT J Am Coll Cardiol 41 1707 1712
27. SA van den Broek DJ van Veldhuisen PA de Graeff ML Landsman H Hillege KI Lie 1992 Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 70 359 363
28. IC van der Horst AA Voors DJ van Veldhuisen 2007 Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists? Clin Res Cardiol 96 193 195
29. Windhagen-Mahnert (2000) Application of noninvasive and invasive tests for risk assessment in patients with ventricular arrhythmias. In: Miller JM (eds) Cardiology Clinic. WB Saunders Co, Philadelphia, pp 243-263
30. W Zareba K Piotrowicz S McNitt AJ Moss 2005 Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population) Am J Cardiol 95 1487 1491